健康之路发盈喜 预计年度利润不低于5000万元 同比扭亏为盈

Core Viewpoint - The company expects to achieve significant revenue and profit growth in 2025, driven by strategic adjustments and new service models, following a challenging 2024 with a net loss. Group 1: Revenue Expectations - The company anticipates revenue for the fiscal year 2025 to be no less than RMB 1.5 billion, representing an increase of at least 25% compared to the fiscal year ending December 31, 2024 [1] - Content service revenue is projected to grow from RMB 577 million in 2024 to at least RMB 800 million in 2025, attributed to strategic adjustments such as resource integration and new service models [1] - Information technology service revenue is expected to rise from RMB 296 million in 2024 to at least RMB 350 million in 2025, primarily due to growth in big data technology services and the launch of AI software products [1] Group 2: Profit Expectations - The company forecasts a profit of no less than RMB 50 million for 2025, a significant turnaround from a net loss of RMB 269 million in 2024 [1] - The AI software products, developed in-house, are projected to contribute approximately RMB 30 million in revenue in their first year of launch in 2025 [1] Group 3: Operational Efficiency - The total operating expenses for 2024, including administrative, sales, and research expenses, accounted for approximately 29% of revenue [1] - The percentage of operating expenses is expected to decrease in 2025 as the business expands [1]

HEALTHYWAY INC-健康之路发盈喜 预计年度利润不低于5000万元 同比扭亏为盈 - Reportify